February 9, 2018
Seattle Science Foundation
550 17th Avenue, James Tower, Suite 600
Seattle, WA 98122
The Innovative Approaches to Brain Tumor Management Course is targeted towards healthcare providers who manage and treat patients with brain tumors. Leading experts in the field will come together to discuss the future of brain tumor management including the progress in personalized medicine and implications of immunotherapy in specializing treatment. The design is to focus on the future of brain tumor therapy with the goal of improving treatment response rates, outcomes, and overall patient care.
Unable to view registration form below? Click here.
SSF is Going Live
Unable to attend in person? This year's conference will be streamed live on Facebook. Click here to view live presentation.
Current research in brain tumor therapy have made profound advances through the use of personalized medicine and immunotherapy, but there remains a significant gap in knowledge regarding treatment progress for many providers. Providers need to be updated on new and future treatment therapies in brain tumor management, develop competence in the future therapies for treating brain tumors, and develop effective treatment plans for patients with malignant, in particular aggressive, brain tumors.
By attending this course, the participant will provide better patient care through an increased ability to:
- Utilize personalized medicine in the treatment of cancer patients
- Integrate current classification system for brain tumors into clinical practice
- Illustrate treatment of brain tumors through the cancer stem cell trials
- Illustrate current obstacles in cancer treatment and demonstrate effective methods for overcoming challenges
- Interpret tumor markers for the treatment of GBM
- Practice personalized medicine in current clinical practice for the treatment of brain tumors
- Interpret current epidemiology and molecular biology of intermediate grade gliomas
- Indicate risks of brain tumor surgery and demonstrate avoidance techniques
- Predict obstacles in treatment of challenging and aggressive brain tumors
- Indicate the risks and benefits of antiviral therapy
- Utilize biomarkers in the treatment of brain tumors
- Indicate benefits of focused therapy in brain tumor management
The sessions are targeted to neurosurgeons, neurooncologists, medical oncologists, neuroradiologists, radiation therapists, and allied health professionals who specialize in the treatment of patients with brain tumors. Geographic Area: Washington, Alaska, Montana, Oregon, Idaho.
Accreditation with Commendation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Swedish Medical Center and the Seattle Science Foundation. Swedish Medical Center is accredited by the ACCME to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
Swedish Medical Center designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This symposium is financially supported in part by educational grants in accordance with ACCME’s Standards for Commercial Support. At the time of this printing, a complete listing of commercial supporters was not available. Appropriate acknowledgment will be given to all supporters at the time of the symposium.
The Seattle Science Foundation is located at 500 17th Avenue, James Tower, Suite 600 in Seattle, Washington. Parking is available in the garage on 16th Avenue between Cherry and Jefferson at a maximum fee of $16.50. From I-5 (northbound and southbound), take the James Street exit. Travel east on James Street. James will become Cherry Street. Turn right (south) on 16th Avenue. Turn right into the main garage entrance.
For Further Information
Phone: (206) 732-6500
Fax: (206) 732-6599